Bozhi Ye

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Top Venues

Circulation research

Phytotherapy research : PTR

Cardiovascular therapeutics

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoxi Fan, Jibo Han, Lingfeng Zhong, Wenyuan Zheng, Ruiyin Shao, Yucong Zhang, Si Shi, Shuang Lin, Zhou-Qing Huang, Wei-Jian Huang, Xueli Cai, Bozhi Ye
Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3/NF-κB Axis. Arteriosclerosis, thrombosis, and vascular biology (2024)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research 132 (4) (2023)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research 132 (4) (2023)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research (2023)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research 132 (4) (2023)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research 132 (4) (2023)
Bozhi Ye, Hao Zhou, Yanghao Chen, Wu Luo, Wante Lin, Ying Zhao, Jibo Han, Xue Han, Wei-Jian Huang, Gaojun Wu, Xu Wang, Guang Liang
USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circulation research 132 (4) (2023)
Yanghao Chen, Wante Lin, Pan Chen, Bozhi Ye, Wu Luo, Xu Wang, Weijian Huang, Gaojun Wu, Guang Liang
Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammation. Phytotherapy research : PTR (2022)
Shuang Lin, Shanshan Dai, Jiahui Lin, Xiaohe Liang, Weiqi Wang, Wei-Jian Huang, Bozhi Ye, Xia Hong
Oridonin Relieves Angiotensin II-Induced Cardiac Remodeling via Inhibiting GSDMD-Mediated Inflammation. Cardiovascular therapeutics 2022 (2022)
Jiahui Lin, Xianhui Lai, Xiaoxi Fan, Bozhi Ye, Lingfeng Zhong, Yucong Zhang, Ruiyin Shao, Si Shi, Weijian Huang, Lan Su, Miaomiao Ying
Oridonin Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting GSDMD-Mediated Pyroptosis. Genes 13 (11) (2022)
Xudong Chen, Shuang Lin, Shanshan Dai, Jibo Han, Peiren Shan, Weiqi Wang, Zhouqing Huang, Bozhi Ye, Weijian Huang
Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 71 (2) (2022)
Jibo Han, Shanshan Dai, Lingfeng Zhong, Xiaowen Shi, Xiaoxi Fan, Xin Zhong, Wante Lin, Lan Su, Shuang Lin, Bingjiang Han, Jianjiang Xu, Xia Hong, Wei-Jian Huang, Bozhi Ye
GSDMD (Gasdermin D) Mediates Pathological Cardiac Hypertrophy and Generates a Feed-Forward Amplification Cascade via Mitochondria-STING (Stimulator of Interferon Genes) Axis. Hypertension (Dallas, Tex. : 1979) 79 (11) (2022)
Shanshan Dai, Bozhi Ye, Longwang Chen, Guangliang Hong, Guangju Zhao, Zhongqiu Lu
Emodin alleviates LPS-induced myocardial injury through inhibition of NLRP3 inflammasome activation. Phytotherapy research : PTR 35 (9) (2021)